Scott Tillman Highlights Uneven Adoption of Generative AI in Supply Chain Operations

Scott Tillman, senior vice president of innovation at Logility, highlighted a notable disparity in the adoption of supply chain-specific applications during a recent video interview. Speaking on the topic, Tillman addressed how organizations are approaching generative AI (GenAI) technologies within their supply chain operations and pointed out gaps in implementation across industries.

Tillman explained that while some companies have embraced GenAI tools to enhance efficiency and decision-making processes, others remain hesitant or slow to adopt these advancements. He noted that this uneven adoption creates challenges for industries aiming to modernize their supply chain systems. The discussion emphasized the importance of understanding how generative AI can be tailored to address specific needs within supply chains, particularly in sectors like pharmaceuticals where precision and reliability are critical.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: May 29, 2025

Related posts:

FDA Study Shows Generic Drugs Match Brand-Name Safety and Efficacy in 99.4% of Cases Generic Drug Makers Must Conduct ICH Guideline Compliant Stability Testing for Freedom to Operate Webinar on June 26, 2025, to Explore Tools for Predicting Market Trends Digital and Laser Printing Technologies Enhance Sustainability in Drug Packaging Manufacturing

Author

Mark Chiang